Chronic Lymphocytic Leukaemia

Chronic lymphocytic leukaemia (CLL) is a cancer of the B-lymphocytes, white blood cells that normally fight infection. Abnormal cells accumulate in the blood, bone marrow, and lymph nodes rather than dying at the end of their natural cycle. CLL tends to progress slowly, many people live with it for years before it requires treatment, and it is the most common adult leukaemia in Western countries, though rates are notably lower across East and South Asia.

Medicine used to treat Chronic Lymphocytic Leukaemia

Leukeran

Chlorambucil

2 · 5mg

Utilized to manage specific types of blood cancers, formulated to slow the progression of malignant cellular growth in the lymphatic system.

From $3.12 / tablet View

How CLL behaves and when treatment begins

Many cases are picked up incidentally on a routine blood test before any symptoms appear. When symptoms do develop they typically include persistent fatigue, swollen lymph nodes in the neck or armpits, night sweats, and a tendency to catch infections more easily. Some people experience an enlarged spleen causing discomfort under the left ribs.

Not every diagnosis calls for immediate treatment. Doctors use staging systems and specific biological markers to judge pace and risk. When treatment is needed, chlorambucil, a long-established alkylating agent, has been a standard option for older or less-fit patients who may not tolerate more intensive regimens. It sits within the broader oncology support range. Regular monitoring of blood counts remains central to management throughout the disease course.